Syndax
Emily Smith is a seasoned professional in the pharmaceutical industry with extensive experience in commercial training, patient access, and strategic development. Currently serving as the National Director of Commercial Training and Development at Syndax Pharmaceuticals, Emily previously held the position of National Associate Director at Amgen, where significant contributions were made to improve patient access in rare diseases. Prior roles include Associate Director at Horizon, where Emily received the top President’s Club honor and led national training initiatives, as well as various leadership positions at Sanofi Genzyme, focusing on training execution and reimbursement processes. Earlier in the career, Emily excelled at Teva Neuroscience, earning awards for leadership and excellence. Emily holds a BBA in Marketing from the SMU Cox School of Business.
This person is not in any teams
This person is not in any offices
Syndax
Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...